Regulatory & Safety

(Image: Getty/Elen11)

The scale of generic uptake in the major markets

By Ben Hargreaves

The divergence across global market penetration of generic medicines is broad, with some countries’ markets worth close to half of the entire sector or as low as one fifth, according to IGBA.

(Image: Getty/Master1305)

WuXi STA’s facility passes first inspection by EMA

By Ben Hargreaves

The company’s Shanghai facility passes the European regulator’s inspection with no ‘critical’ or ‘major’ findings regarding the commercial products produced at the site.

(Image: Getty/BobHemphill)

Takeda sheds products in emerging markets in $200m deal

By Ben Hargreaves

Takeda has sold selected prescription and OTC products to Acino covering its Near East, Middle East and Africa portfolio, as it looks to trim down its portfolio following the acquisition of Shire.